BGLAP and atherosclerosis: In a mouse model of atherosclerosis, daily injections of osteocalcin reduced the risk of CVD, which showed an endothelial-protective effect because it improves glucose and lipid metabolism by activating the PI3K-Akt-eNOS signaling pathway (25).